AU522049B2 - Treatment of psoriasis - Google Patents

Treatment of psoriasis

Info

Publication number
AU522049B2
AU522049B2 AU32414/78A AU3241478A AU522049B2 AU 522049 B2 AU522049 B2 AU 522049B2 AU 32414/78 A AU32414/78 A AU 32414/78A AU 3241478 A AU3241478 A AU 3241478A AU 522049 B2 AU522049 B2 AU 522049B2
Authority
AU
Australia
Prior art keywords
psoriasis
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU32414/78A
Other versions
AU3241478A (en
Inventor
Joseph Van Scott And Riley Jon Yu Eugene
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Van Scott Eugene Joseph
Original Assignee
SCOTT E J VAN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SCOTT E J VAN filed Critical SCOTT E J VAN
Priority to AU32414/78A priority Critical patent/AU522049B2/en
Publication of AU3241478A publication Critical patent/AU3241478A/en
Application granted granted Critical
Publication of AU522049B2 publication Critical patent/AU522049B2/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
AU32414/78A 1978-01-13 1978-01-13 Treatment of psoriasis Expired AU522049B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU32414/78A AU522049B2 (en) 1978-01-13 1978-01-13 Treatment of psoriasis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU32414/78A AU522049B2 (en) 1978-01-13 1978-01-13 Treatment of psoriasis

Publications (2)

Publication Number Publication Date
AU3241478A AU3241478A (en) 1979-07-19
AU522049B2 true AU522049B2 (en) 1982-05-13

Family

ID=3719928

Family Applications (1)

Application Number Title Priority Date Filing Date
AU32414/78A Expired AU522049B2 (en) 1978-01-13 1978-01-13 Treatment of psoriasis

Country Status (1)

Country Link
AU (1) AU522049B2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0083779A1 (en) * 1982-01-04 1983-07-20 Karl H. Beyer, Jr. Hyperuretic agents
WO1986006628A1 (en) * 1985-05-03 1986-11-20 Sri International Benzamide and nicotinamide radiosensitizers
WO1992021317A1 (en) * 1991-06-04 1992-12-10 L'oreal Pyridine 1-oxide based composition for combatting hair loss and for inducing and stimulating hair growth

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0083779A1 (en) * 1982-01-04 1983-07-20 Karl H. Beyer, Jr. Hyperuretic agents
WO1986006628A1 (en) * 1985-05-03 1986-11-20 Sri International Benzamide and nicotinamide radiosensitizers
GB2185254A (en) * 1985-05-03 1987-07-15 Stanford Res Inst Int Benzamide and nicotinamide radiosensitizers
GB2185254B (en) * 1985-05-03 1989-09-13 Stanford Res Inst Int Benzamide and nicotinamide radiosensitizers
WO1992021317A1 (en) * 1991-06-04 1992-12-10 L'oreal Pyridine 1-oxide based composition for combatting hair loss and for inducing and stimulating hair growth
FR2677247A1 (en) * 1991-06-04 1992-12-11 Oreal COMPOSITION FOR BRAKING THE FALL OF HAIR AND FOR INDUCING AND STIMULATING THEIR GROWTH, BASED ON PYRIDINE-1 OXIDE DERIVATIVES.

Also Published As

Publication number Publication date
AU3241478A (en) 1979-07-19

Similar Documents

Publication Publication Date Title
GB2018589B (en) Treatment of acne
AU528476B2 (en) Iontophoretic treatment
AU527034B2 (en) Skin treatment compositions
AU530553B2 (en) Treatment of textile materials
AU529680B2 (en) Plasma treatment of materials
AU526044B2 (en) Camphorates of d carnitinamide
AU4876479A (en) Plant extraction for treatment of psoriasis
AU4748079A (en) Anti-corrosion treatment
AU524491B2 (en) Purification of rutile
AU533516B2 (en) Manufacture of aza-spirodecanes
AU523152B2 (en) Treatment of reinforcing silicas with amidosiloxanes
JPS5562986A (en) Treatment of biomass
AU522049B2 (en) Treatment of psoriasis
AU531413B2 (en) Non-polluting treatment of uraniferous effluents
AU517602B2 (en) Thermal treatment of polyelthylene
AU514663B2 (en) Treatment of asthma
AU528631B2 (en) Treatment of lead concentrate
AU527958B2 (en) Cancer treatment
JPS5558055A (en) Treating of euphausiacea
AU530634B2 (en) Treatment of carbonaceous materials
AU4603579A (en) Treatment of pancreas
AU535700B2 (en) Treatment of metallic surfaces
AU522585B2 (en) Treatment of tobacco
AU527653B2 (en) Effluent treatment
AU560510B2 (en) Effluent treatment